Cargando…

Increased Neutrophil Aging Contributes to T Cell Immune Suppression by PD-L1 and Arginase-1 in HIV-1 Treatment Naïve Patients

Neutrophils are characterized by their heterogeneity. They fight against pathogens and are involved in tissue injury repair and immune system regulation. Neutrophils have an extremely short life span in the peripheral blood and undergo aging after being released from the bone marrow. The over-aggreg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Kai, Huang, Hui-Huang, Yang, Tao, Jiao, Yan-Mei, Zhang, Chao, Song, Jin-Wen, Zhang, Ji-Yuan, Zhou, Chun-Bao, Yuan, Jin-Hong, Cao, Wen-Jing, Mu, Xiu-Ying, Zhou, Ming-Ju, Li, Hua-Jie, Shi, Ming, Xu, Ruonan, Wang, Fu-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416527/ https://www.ncbi.nlm.nih.gov/pubmed/34489929 http://dx.doi.org/10.3389/fimmu.2021.670616

Ejemplares similares

Reversal of the CD8(+) T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways
por: Li, Jing, et al.
Publicado: (2021)

Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis
por: Sun, Rui, et al.
Publicado: (2020)

Expression of CD39 Is Correlated With HIV DNA Levels in Naïve Tregs in Chronically Infected ART Naïve Patients
por: Song, Jin-Wen, et al.
Publicado: (2019)

HIV-1-Specific CD11c(+) CD8(+) T Cells Display Low PD-1 Expression and Strong Anti-HIV-1 Activity
por: Guo, An-Liang, et al.
Publicado: (2021)

Elevation of Arginase-II in Podocytes Contributes to Age-Associated Albuminuria in Male Mice
por: Ajalbert, Guillaume, et al.
Publicado: (2023)

Low expression of CXCR1/2 on neutrophils predicts poor survival in patients with hepatitis B virus-related acute-on-chronic liver failure
por: Xu, Ruonan, et al.
Publicado: (2016)

Liver-specific knockout of arginase-1 leads to a profound phenotype similar to inducible whole body arginase-1 deficiency
por: Ballantyne, Laurel L., et al.
Publicado: (2016)

Arginase-II activates mTORC1 through myosin-1b in vascular cell senescence and apoptosis
por: Yu, Yi, et al.
Publicado: (2018)

Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil Granulocytes
por: Vonwirth, Verena, et al.
Publicado: (2021)

Role of tubular epithelial arginase-II in renal inflammaging
por: Huang, Ji, et al.
Publicado: (2021)

PD-L1(+) neutrophils contribute to injury-induced infection susceptibility
por: Thanabalasuriar, Ajitha, et al.
Publicado: (2021)

Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway
por: Bowers, Nathan L., et al.
Publicado: (2014)

Inhibition of S6K1 accounts partially for the anti-inflammatory effects of the arginase inhibitor L-norvaline
por: Ming, Xiu-Fen, et al.
Publicado: (2009)

Arginase 1 is a key driver of immune suppression in pancreatic cancer
por: Menjivar, Rosa E, et al.
Publicado: (2023)

Elevated glutamate impedes anti-HIV-1 CD8 + T cell responses in HIV-1-infected individuals on antiretroviral therapy
por: Wang, You-Yuan, et al.
Publicado: (2023)

Arginase: The Emerging Therapeutic Target for Vascular Oxidative Stress and Inflammation
por: Yang, Zhihong, et al.
Publicado: (2013)

Neutrophils drive endoplasmic reticulum stress-mediated apoptosis in cancer cells through arginase-1 release
por: García-Navas, Rósula, et al.
Publicado: (2021)

From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
por: Zhao, Xuan, et al.
Publicado: (2022)

Arginase-II Deficiency Extends Lifespan in Mice
por: Xiong, Yuyan, et al.
Publicado: (2017)

Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection
por: Wan, Lin-Yu, et al.
Publicado: (2022)

Activation-induced pyroptosis contributes to the loss of MAIT cells in chronic HIV-1 infected patients
por: Xia, Peng, et al.
Publicado: (2022)

Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway
por: Wang, Ting-ting, et al.
Publicado: (2017)

Arginase-II negatively regulates renal aquaporin-2 and water reabsorption
por: Huang, Ji, et al.
Publicado: (2018)

Strategies to Rescue the Consequences of Inducible Arginase-1 Deficiency in Mice
por: Ballantyne, Laurel L., et al.
Publicado: (2015)

Androgen-Regulated Expression of Arginase 1, Arginase 2 and Interleukin-8 in Human Prostate Cancer
por: Gannon, Philippe O., et al.
Publicado: (2010)

An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial
por: Grauslund, Jacob Handlos, et al.
Publicado: (2023)

The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: A Systematic Review and Meta-Analysis
por: Chen, Xiao-Jiang, et al.
Publicado: (2020)

Annexin A2/TLR2/MYD88 pathway induces arginase 1 expression in tumor-associated neutrophils
por: Zhang, Huajia, et al.
Publicado: (2022)

Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis
por: Nie, Run-Cong, et al.
Publicado: (2021)

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
por: Niu, Mengke, et al.
Publicado: (2022)

miR-140-3p Suppresses Cell Growth And Induces Apoptosis In Colorectal Cancer By Targeting PD-L1
por: Jiang, Wei, et al.
Publicado: (2019)

The PD-L1/PD-1 Axis Blocks Neutrophil Cytotoxicity in Cancer
por: Yajuk, Olga, et al.
Publicado: (2021)

Interleukin‐17E, inducible nitric oxide synthase and arginase1 as new biomarkers in the identification of neutrophilic dermatoses
por: Stalder, R., et al.
Publicado: (2021)

Correction: Possible Role of Arginase-1 in Concomitant Tumor Immunity
por: Korrer, Michael J., et al.
Publicado: (2016)

Hypoxia Enhances Endothelial Intercellular Adhesion Molecule 1 Protein Level Through Upregulation of Arginase Type II and Mitochondrial Oxidative Stress
por: Liang, Xiujie, et al.
Publicado: (2019)

Neutrophil depletion enhances the therapeutic effect of PD-1 antibody on glioma
por: Wang, Peng-Fei, et al.
Publicado: (2020)

Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency
por: Sin, Yuan Yan, et al.
Publicado: (2017)

The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy
por: Wen, Lu, et al.
Publicado: (2021)

Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
por: He, Gaixia, et al.
Publicado: (2015)

Circulating neutrophils activated by cancer cells and M2 macrophages promote gastric cancer progression during PD-1 antibody-based immunotherapy
por: Zhou, Chenfei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2n7borgqvlpink9u0rauf3v3d4